about
Interleukin-6: a new therapeutic targetJAK/STAT but not ERK1/ERK2 pathway mediates interleukin (IL)-6/soluble IL-6R down-regulation of Type II collagen, aggrecan core, and link protein transcription in articular chondrocytes. Association with a down-regulation of SOX9 expressionComparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION studyc-Cbl-dependent monoubiquitination and lysosomal degradation of gp130Interleukin-6- and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells.Association Between Interleukin-6 -572 C>G and -174 G>C Polymorphisms and Hypertension: A Meta-analysis of Case-control StudiesInflammatory cytokines in systemic lupus erythematosusAssociation between interleukin-6 gene polymorphisms and bone mineral density: a meta-analysisInterleukin-6 myokine signaling in skeletal muscle: a double-edged sword?Revisiting the 1986 molecular cloning of interleukin 6The pathological and physiological roles of IL-6 amplifier activationCurrent concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy.Roles of keratinocyte inflammation in oral cancer: regulating the prostaglandin E2, interleukin-6 and TNF-alpha production of oral epithelial cells by areca nut extract and arecolineActivation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathwaysFunction and molecular modeling of the interaction between human interleukin 6 and its HNK-1 oligosaccharide ligandsPrevention of hypovolemic circulatory collapse by IL-6 activated Stat3Myelin basic protein induces inflammatory mediators from primary human endothelial cells and blood-brain barrier disruption: implications for the pathogenesis of multiple sclerosisAntigen distribution of TMUV and GPV are coincident with the expression profiles of CD8α-positive cells and goose IFNγ.Extracellular hepatitis C virus core protein activates STAT3 in human monocytes/macrophages/dendritic cells via an IL-6 autocrine pathway.Enhancing or eliminating signals for cell survival to treat disease.PGE2 induces IL-6 in orbital fibroblasts through EP2 receptors and increased gene promoter activity: implications to thyroid-associated ophthalmopathy.Interleukin-6 represses the transcription of the CCAAT/enhancer binding protein-alpha gene in hepatoma cells by inhibiting its ability to autoactivate the proximal promoter regionClone-specific expression, transcriptional regulation, and action of interleukin-6 in human colon carcinoma cellsPoint mutation of tyrosine 759 of the IL-6 family cytokine receptor, gp130, augments collagen-induced arthritis in DBA/1J mice.Neurotrophins regulate bone marrow stromal cell IL-6 expression through the MAPK pathwayInterleukin-6 Signaling Pathway and Its Role in Kidney Disease: An UpdateLung parenchyma-derived IL-6 promotes IL-17A-dependent acute lung injury after allogeneic stem cell transplantationSignaling through Gp130: toward a general scenario of cytokine action.Hypoxia-Inducible Factor 1α Is a Critical Downstream Mediator for Hypoxia-Induced Mitogenic Factor (FIZZ1/RELMα)-Induced Pulmonary Hypertension.Interleukin 6 and liver regenerationBoth Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans.Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitisThe interleukin-6 -174G/C polymorphism and prostate cancer risk: a systematic review and meta-analysis.Modulation of the interleukin-6 receptor subunit glycoprotein 130 complex and its signaling by LMO4 interaction.Cross talk between peritoneal macrophages and B-1 cells in vitro.Hematopoietic cytokines.Interleukin 6 in autoimmune and inflammatory diseases: a personal memoirIL-6 activates serum and glucocorticoid kinase via p38alpha mitogen-activated protein kinase pathway.Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes.Cytokines in multiple sclerosis: methodological aspects and pathogenic implications.
P2860
Q21195659-E9FF64A5-3C7A-4998-81C3-81BEAFE72B02Q24316553-CAC15F43-451A-4419-99CE-D4B27497D907Q24630541-E853E8CF-72A5-40F1-B042-BD53C1452A29Q24651018-48C8DAF7-D779-4B30-A1AF-885313C605F1Q24746259-0DB9BF23-6695-4952-8112-990153003517Q26772066-B03D3E08-1452-42C7-B8F4-6AB319943612Q26823647-4A3FF7DE-FBDD-4C4D-8815-83998F7749C9Q26852408-B76F5560-D601-4FE5-92A2-2B3F65BD54F8Q26866208-5567AA3C-E4FC-4215-B66E-713BD0F91008Q26998608-DACEA4C3-6E79-4A03-91B6-4DF5C54521AFQ27690908-108F4919-429A-4FC7-AF20-E4116A6F1F37Q27691806-8C9F8CA4-1834-485D-BA79-912E1D8ECC05Q28196459-783E48F0-A8E7-4F76-88F2-A15AA022CA18Q28212733-237059B7-9C23-48A1-B56F-E73D03E38443Q28215310-50E70205-706E-4CC9-BE88-C7CEBBDFFA9DQ28576610-D8238175-280B-41F0-B5E0-6A33E1ACC146Q28910423-B3DFEF0B-6632-420D-BFC3-1945214E3682Q30387743-9E771204-300A-4819-A966-EC32CFAB3D60Q30427748-C718C56E-329E-40B7-9CA3-BB20B9E9C6BCQ30498584-729EE8BE-095F-427A-863B-EF407D76C398Q30994732-1479A224-1156-45B6-B64A-096EF4501575Q33195176-05EBCD98-F469-4004-BA65-FB48C15D5039Q33315459-6A8DBE33-AC2E-4456-A947-227A1D6A45C5Q33410688-BFA3A5CE-9914-4C11-903F-5295878F06FFQ33543136-5E852778-9871-4AD8-B45B-B64A20018794Q33586501-A6C29C6F-B410-41D9-BAB4-B79B8F38C0EBQ33758318-F0F76301-E9C9-4B5B-8D36-7F0279A637D4Q33792910-A321A699-3C42-48AB-B06D-0CCCB5688B05Q33920050-04710C38-C6BC-4FB9-87E5-85FAE1180C71Q33969763-42778389-0FB0-4F0F-8312-5093DFE701CFQ34009446-7107F352-4B1A-4E7D-82FB-58E7F8E0B58CQ34116480-4CEC38A3-8A99-457D-9493-5554D1E809EDQ34239802-85F606C6-7127-4655-B1F6-EF9174DE2747Q34389028-63F10B9A-5F51-4FD5-94EE-C4BF11A79A9EQ34717757-77D8B2A6-1C4C-4F12-8778-80636BEF70D1Q34734185-748D8FD0-C7E4-4894-89CA-A6E79EA0F312Q34734696-A48191F9-7F1C-4C13-BCE5-448E6E7016D9Q34804514-0D597DCB-E935-4A1C-9392-F5C80B5B6DBCQ34881846-F58DE658-1934-4D43-BC6E-6A28852865A5Q34924266-5647E3FF-9856-4AD9-BFE5-B6EEE1A5FC83
P2860
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Interleukin 6 and its receptor: ten years later.
@en
type
label
Interleukin 6 and its receptor: ten years later.
@en
prefLabel
Interleukin 6 and its receptor: ten years later.
@en
P2860
P1476
Interleukin 6 and its receptor: ten years later.
@en
P2093
P2860
P304
P356
10.3109/08830189809042997
P577
1998-01-01T00:00:00Z